NCT04443725 Efficacy and Safety of Anti HCV Drugs in the Treatment of COVID-19 Status UNKNOWN Phase PHASE2/PHASE3
NCT04443270 Chloroquine Phosphate Prophylactic Use in Health Personnel Exposed to COVID-19 Patients Status UNKNOWN Phase PHASE1
NCT04443140 Preeclampsia-like Syndrome Induced by COVID-19: Is it a Real Public Health Issue in Pregnancy During the Pandemic? Status COMPLETED Phase N/A
NCT04442178 InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) Status TERMINATED Phase PHASE2
NCT04442165 Characterising Transmission of SARS-CoV-2 in a Peri-urban Population in Mozambique Status COMPLETED Phase N/A
NCT04442048 Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure Status COMPLETED Phase PHASE3
NCT04441996 Therapeutic Plasma Exchange for COVID-19-associated Hyperviscosity Status COMPLETED Phase PHASE4
NCT04441385 Study to Evaluate the Efficacy and Safety of Maraviroc in SARS-CoV-2 Infection (COVID-19). Status TERMINATED Phase PHASE2
NCT04440007 Study of the Efficacy and Safety of STI-5656 (Abivertinib Maleate) in Subjects Hospitalized With COVID-19 Status COMPLETED Phase PHASE2
NCT04439071 A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19) Status TERMINATED Phase PHASE2/PHASE3
NCT04438954 Investigation of Fatigue, Physical Activity, Sleep Quality and Anxiety Levels Status COMPLETED Phase N/A
NCT04438057 Evaluating the Efficacy of Convalescent Plasma in Symptomatic Outpatients Infected With COVID-19 Status COMPLETED Phase PHASE2
NCT04437719 Prospective Cohort Study to Describe the Clinical Characteristics of COVID-19, the Acquired Immune Response and the Biological and Clinical Parameters of Patients Followed in Oncology by the Saint-Joseph Hospital Group for a Period of 6 Months During the COVID-19 Pandemic Status COMPLETED Phase NA